Literature DB >> 20101763

Probiotics and gut health: a special focus on liver diseases.

Silvia Wilson Gratz, Hannu Mykkanen, Hani S El-Nezami.   

Abstract

Probiotic bacteria have well-established beneficial effects in the management of diarrhoeal diseases. Newer evidence suggests that probiotics have the potential to reduce the risk of developing inflammatory bowel diseases and intestinal bacterial overgrowth after gut surgery. In liver health, the main benefits of probiotics might occur through preventing the production and/or uptake of lipopolysaccharides in the gut, and therefore reducing levels of low-grade inflammation. Specific immune stimulation by probiotics through processes involving dendritic cells might also be beneficial to the host immunological status and help prevent pathogen translocation. Hepatic fat metabolism also seems to be influenced by the presence of commensal bacteria, and potentially by probiotics; although the mechanisms by which probiotic might act on the liver are still unclear. However, this might be of major importance in the future because low-grade inflammation, hepatic fat infiltration, and hepatitis might become more prevalent as a result of high fat intake and the increased prevalence of obesity.

Entities:  

Mesh:

Year:  2010        PMID: 20101763      PMCID: PMC2811790          DOI: 10.3748/wjg.v16.i4.403

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  55 in total

Review 1.  Antiallergic effects of probiotics.

Authors:  Arthur C Ouwehand
Journal:  J Nutr       Date:  2007-03       Impact factor: 4.798

2.  The effect of probiotics on gut flora, level of endotoxin and Child-Pugh score in cirrhotic patients: results of a double-blind randomized study.

Authors:  Jan Lata; Ivo Novotný; Veronika Príbramská; Jana Juránková; Premysl Fric; Radek Kroupa; Oldrich Stibůrek
Journal:  Eur J Gastroenterol Hepatol       Date:  2007-12       Impact factor: 2.566

3.  Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

Authors:  P D Cani; A M Neyrinck; F Fava; C Knauf; R G Burcelin; K M Tuohy; G R Gibson; N M Delzenne
Journal:  Diabetologia       Date:  2007-09-06       Impact factor: 10.122

4.  Panorganismal gut microbiome-host metabolic crosstalk.

Authors:  Francois-Pierre J Martin; Norbert Sprenger; Ivan K S Yap; Yulan Wang; Rodrigo Bibiloni; Florence Rochat; Serge Rezzi; Christine Cherbut; Sunil Kochhar; John C Lindon; Elaine Holmes; Jeremy K Nicholson
Journal:  J Proteome Res       Date:  2009-04       Impact factor: 4.466

Review 5.  Safety of probiotics: translocation and infection.

Authors:  Min-Tze Liong
Journal:  Nutr Rev       Date:  2008-04       Impact factor: 7.110

6.  Endotoxin- and D-galactosamine-induced liver injury improved by the administration of Lactobacillus, Bifidobacterium and blueberry.

Authors:  N Osman; D Adawi; S Ahrné; B Jeppsson; G Molin
Journal:  Dig Liver Dis       Date:  2007-07-25       Impact factor: 4.088

7.  Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function.

Authors:  K C Johnson-Henry; K A Donato; G Shen-Tu; M Gordanpour; P M Sherman
Journal:  Infect Immun       Date:  2008-01-28       Impact factor: 3.441

8.  Lactobacillus rhamnosus strain GG reduces aflatoxin B1 transport, metabolism, and toxicity in Caco-2 Cells.

Authors:  S Gratz; Q K Wu; H El-Nezami; R O Juvonen; H Mykkänen; P C Turner
Journal:  Appl Environ Microbiol       Date:  2007-04-20       Impact factor: 4.792

9.  Symbiotic gut microbes modulate human metabolic phenotypes.

Authors:  Min Li; Baohong Wang; Menghui Zhang; Mattias Rantalainen; Shengyue Wang; Haokui Zhou; Yan Zhang; Jian Shen; Xiaoyan Pang; Meiling Zhang; Hua Wei; Yu Chen; Haifeng Lu; Jian Zuo; Mingming Su; Yunping Qiu; Wei Jia; Chaoni Xiao; Leon M Smith; Shengli Yang; Elaine Holmes; Huiru Tang; Guoping Zhao; Jeremy K Nicholson; Lanjuan Li; Liping Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-05       Impact factor: 11.205

10.  Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model.

Authors:  Francois-Pierre J Martin; Yulan Wang; Norbert Sprenger; Ivan K S Yap; Torbjörn Lundstedt; Per Lek; Serge Rezzi; Ziad Ramadan; Peter van Bladeren; Laurent B Fay; Sunil Kochhar; John C Lindon; Elaine Holmes; Jeremy K Nicholson
Journal:  Mol Syst Biol       Date:  2008-01-15       Impact factor: 11.429

View more
  28 in total

1.  Gut region-dependent alterations of nitrergic myenteric neurons after chronic alcohol consumption.

Authors:  Mária Bagyánszki; Nikolett Bódi
Journal:  World J Gastrointest Pathophysiol       Date:  2015-08-15

Review 2.  Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease.

Authors:  Tannaz Eslamparast; Sareh Eghtesad; Hossein Poustchi; Azita Hekmatdoost
Journal:  World J Hepatol       Date:  2015-02-27

Review 3.  Probiotics in hepatology.

Authors:  Jan Lata; Jana Jurankova; Marcela Kopacova; Petr Vitek
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

4.  Effect of probiotics and synbiotics consumption on serum concentrations of liver function test enzymes: a systematic review and meta-analysis.

Authors:  Saman Khalesi; David Wayne Johnson; Katrin Campbell; Susan Williams; Andrew Fenning; Sonia Saluja; Christopher Irwin
Journal:  Eur J Nutr       Date:  2017-11-08       Impact factor: 5.614

5.  Protective effects of Lactobacillus plantarum against epithelial barrier dysfunction of human colon cell line NCM460.

Authors:  Zhi-Hua Liu; Tong-Yi Shen; Peng Zhang; Yan-Lei Ma; Mary Pat Moyer; Huan-Long Qin
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

Review 6.  Targeting gut microbiota in hepatocellular carcinoma: probiotics as a novel therapy.

Authors:  Murphy L Y Wan; Hani El-Nezami
Journal:  Hepatobiliary Surg Nutr       Date:  2018-02       Impact factor: 7.293

7.  Survival of Planktonic and Sessile Cells of Lactobacillus rhamnosus and Lactobacillus reuteri upon Exposure to Simulated Fasting-State Gastrointestinal Conditions.

Authors:  Kyle B Klopper; Elanna Bester; Shelly M Deane; Gideon M Wolfaardt; Leon M T Dicks
Journal:  Probiotics Antimicrob Proteins       Date:  2019-06       Impact factor: 4.609

8.  Hepatoprotective Effect of Probiotic Lactic Acid Bacteria on Thioacetamide-Induced Liver Fibrosis in Rats.

Authors:  Chittapon Jantararussamee; Siripa Rodniem; Malai Taweechotipatr; Udomsri Showpittapornchai; Wisuit Pradidarcheep
Journal:  Probiotics Antimicrob Proteins       Date:  2021-02       Impact factor: 4.609

9.  Impact of perioperative symbiotic therapy on infectious morbidity after Hpb Surgery in jaundiced patients: a randomized controlled trial.

Authors:  N Russolillo; A Ferrero; L Vigano'; S Langella; A Briozzo; M Ferlini; M Migliardi; L Capussotti
Journal:  Updates Surg       Date:  2014-08-07

10.  Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease.

Authors:  Arthur W Yan; Bernd Schnabl
Journal:  World J Hepatol       Date:  2012-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.